CUL3

Cullin-3 · Q13618 · CUL3 on Sugi Atlas →

0 patent compounds predicted against CUL3, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to CUL3 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitors on Sarcopenia in Hemodialysis Patients PHASE4NOT_YET_RECRUITING
Can We Achieve 'high-quality' Weight Loss Through Supplementation and Exercise? the TRIM MUSCLE Study PHASE3COMPLETED
Effect of Deferoxamine on Wound Healing Rate in Patients With Diabetes Foot Ulcers PHASE2NOT_YET_RECRUITING
Phase II Study of Vandetanib in Individuals With Kidney Cancer PHASE2COMPLETED
Olaparib in Patients With HRD Malignant Mesothelioma PHASE2RECRUITING
GO-203-2C + Bortezomib For Relapsed Or Refractory MM PHASE1WITHDRAWN
A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7248824 in Participants With Angelman Syndrome (AS) PHASE1COMPLETED
PS-341 and Radiation to Treat Advanced Cancer of the Head and Neck PHASE1COMPLETED
Impact of Nrf2 Activation on Macrovascular, Microvascular & Leg Function & Walking Capacity in Peripheral Artery Disease EARLY_PHASE1RECRUITING
ADAPT: Efficacy of a Dietary Supplement During and After Exercise nanCOMPLETED
Prognostic Value of Combined Approach Based on KEAP1/NFE2L2 Mutations and Pre-therapeutic FDG-PET/CT Radiomic Analysis in Advanced Non-small-cell Lung Cancer PDL1 ≥ 50% Treated With Pembrolizumab (PEMBROMIC) nanUNKNOWN
Clinical Study of 68Ga-DOTA-BLP PET Imaging in Noninvasive Diagnosis of Malignant Tumors nanNOT_YET_RECRUITING
The Role of RING Ubiquitin Ligases in Biologic and Oncologic Processes in Tissues of Mesenchymal Origin nanUNKNOWN
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis nanUNKNOWN
Assessment of Residual VHL Function in Tumors - Can it Predict the Patients' Individual Course of Disease? nanUNKNOWN
Drivers of Hypoxia-induced Angiogenesis in Tumor Development nanUNKNOWN
Natural History and Management of Pancreatic Lesions in Von Hippel-Lindau Disease nanCOMPLETED
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders nanRECRUITING
Ohio Colorectal Cancer Prevention Initiative nanCOMPLETED
DDX3X Syndrome -The Seaver Autism Center for Research and Treatment is Characterizing DDX3X-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures. nanCOMPLETED
Refining Information Technology Support for Genetics in Medicine nanUNKNOWN
Study of Individuals and Families With Aberrations in DDX41 or Similar Cancer Predisposition Variants nanRECRUITING
Screening for Endolymphatic Sac Tumours (ELSTs) in Von Hippel-Lindau (vHL) Patients nanRECRUITING
Long Term Follow-Up of Patients With Mesothelioma and Individuals With Germline Mutations in BAP1 nanRECRUITING
Better Delineation of DDX3X Related Phenotype and Epigenetic Signature. nanUNKNOWN
Mitochondrial Activity and Myosteatosis in the Cachexia of Cancers of the Upper Aerodigestive Tract nanUNKNOWN
A New Approach to Cervical Cancer Prevention in Kenya nanCOMPLETED
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a CUL3 binder may also engage these)

ProteinNameSimilarity
Q6GPF3 1.000 Q6GPF3 →
Q6DE95 1.000 Q6DE95 →
Q9JLV5 1.000 Q9JLV5 →
A4IHP4 1.000 A4IHP4 →
P0CH31 1.000 P0CH31 →
Q94AH6 1.000 Q94AH6 →
Q9ZVH4 1.000 Q9ZVH4 →
Q17390 0.999 Q17390 →
Q9C9L0 0.999 Q9C9L0 →
CUL2 Cullin-2 0.998 landscape →
O60999 0.998 O60999 →
B5DF89 0.998 B5DF89 →
Q17391 0.997 Q17391 →
Q54NZ5 0.997 Q54NZ5 →
Q24311 0.996 Q24311 →
Q5RCF3 0.995 Q5RCF3 →
O13790 0.995 O13790 →
Q17389 0.994 Q17389 →
Q23639 0.992 Q23639 →
Q5ZC88 0.990 Q5ZC88 →
Q9D4H8 0.990 Q9D4H8 →
Q09760 0.989 Q09760 →
Q9SRZ0 0.988 Q9SRZ0 →
O14122 0.987 O14122 →
Q12018 0.987 Q12018 →
Q9XIE8 0.986 Q9XIE8 →
Q86T65 0.984 Q86T65 →
Q20938 0.983 Q20938 →
Q5U3P0 0.982 Q5U3P0 →
Q54CS2 0.982 Q54CS2 →